Últimos Artículos de Lancet Diabetes & Endocrinology
- [In Focus] Alka Kanaya: representation in epidemiology
- [Editorial] What's in a decade?
- [Review] Current insights and emerging trends in early-onset type 2 diabetes
- [Articles] Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation
- [Comment] Many years of life lost to young-onset type 2 diabetes
- [Articles] The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysis
- [Comment] Is it time to re-assess the development of thyroid function reference ranges?
- [Correspondence] Craniopharyngioma: medico-social support for optimised care
- [Review] Maternal type 1 diabetes and relative protection against offspring transmission
- [Comment] The TRAVERSE trial: cardiovascular safety of testosterone therapy for older men
- [Comment] Call for prospective studies of continuous glucose monitoring to define the glycaemic response to bariatric surgery
- [In Focus] Carmella Evans-Molina: being of service
- [Comment] Built environment and obesity prevention research: moving from niche to norm
- [Corrections] Correction to Lancet Diabetes Endocrinol 2023; 11: 402–13
- [Correspondence] Tuning of cellular insulin release by music for real-time diabetes control
- [Articles] Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study
- [Comment] Good news for patients with adrenocortical carcinoma from the ADIUVO trial
- [Editorial] Eating disorders: care not keeping up with demand
- [Corrections] Correction to Lancet Diabetes Endocrinol 2023; 11: 490–508
- [Review] National UK guidelines for the management of paediatric craniopharyngioma